期刊文献+

三维适形放疗急性放射性食管炎影响因素的临床研究 被引量:16

Risk factors related to acute radiation esophagitis induced by 3-dimension conformal radiotherapy
下载PDF
导出
摘要 目的探讨胸部恶性肿瘤三维适形放疗所引起的急性放射性食管炎的发生率和影响因素。方法60例非小细胞肺癌和食管癌患者进入本研究,单纯三维适形放疗39例,放疗、化疗同期治疗21例,化疗采用CMV或FP方案。患者临床特征和治疗参数指标包括:性别、年龄、是否同期化疗、射野内食管长度、整个食管的平均剂量、食管的最大剂量点剂量。针对RTOG分级≥2级的急性放射性食管炎患者分析上述指标。结果26例(43.3%)患者出现了≥2级的急性放射性食管炎,其中2级18例(69.2%);3级7例(26.9%);4级1例(3.9%)。发现同期放疗、化疗和整个食管的平均剂量对急性放射性食管炎的发生是有统计学意义的影响因素(P<0.05)。结论在三维适形放疗中,同期放疗、化疗和整个食管的平均剂量是急性放射性食管炎发生的影响因素。 Objective To investigate the risk factors related to acute esophagitis induced by 3-dimension conformal radiation therapy (3D-CRT) for cancers in the thorax. Methods Sixty patients with lung cancer and esophageal cancer were recruited in the study from October 2003 to January 2006. Thirty-nine patients were treated with 3D-CRT alone and 21 patients received concurrent chemotherapy (CMV or FP regimens). The following parameters were analyzed against esophagitis of grade 2 or above on RTOG criteria: gender,age,current chemotherapy; length of esophagus in treatment field, mean dose to the entire esophagus and maximal point dose to esophagus. Results Acute radiation esophagitis occurred in 26 patients(43. 3%)with 18(69. 2%) in grade 2, 7(26. 9%) in grade 3,and 1(3. 9%) in grade 4,respectively. Concurrent chemotherapy and mean dose to the entire esophagus demonstrated a statistically significant correlation with the incidence of esophagitis. Conclusion Concurrent chemotherapy and mean dose to the entire esophagus are the risk factors related to radiation esophagitis in patients treated with 3D-CRT.
出处 《实用肿瘤杂志》 CAS 2007年第4期314-316,共3页 Journal of Practical Oncology
基金 卫生部标准基金项目(2003)
关键词 非小细胞肺/放射疗法 食管炎病因学 食管肿瘤/放射疗法 放射疗法 适形/副作用 辐射损伤/并发症 carcinoma, non-small-cell lung/radiotherapy esophagitis/etiology esophageal neoplasms/radiotherapy radiotherapy, conformal/adverse effects radiation injuries/complication acute disease
  • 相关文献

参考文献8

  • 1Cox JD,Stetz J,Pajak TF.Toxicity criteria of the radiation therapy oncology group (RTOG) and the european organization for research and treatment of cancer (EORTC)[J].Int J Radiat Oncol Biol Phys,1995,31(5):1341-1346.
  • 2Choy H,Vokes E.Improving outcomes in the treatment of locally advanced NSCLC with gemcitabine[J].Lung Cancer,2005,50(1):10-12.
  • 3Werner-Wasik M,Pequignot E,Hauck W.A multivariate analysis of esophagitis grade and esophagitis index in patients with lung cancer[J].Int J Radiat Oncol,1999,45(3):154-155.
  • 4Langer C,Hudes R,Movsas B,et al.,Induction paclitaxel and carboplatin followed by concurrent chemoradiotherapy in unresectable,locally advanced non-small cell lung carcinoma[J].Lung Cancer,1997,18(1):74-79.
  • 5Maguire J,Kelly V,Page R,et al.Accelerated hypofractionated radical radiotherapy concurrent with cisplatinum and vinorelbine for inoperable NSCLC[J].Lung Cancer,2005,49(2):171-175.
  • 6Hirota S,Tsujino K,Hishikawa Y,et al.Endoscopical findings of radiation esophagitis in concurrent chemoradiation for intrathoracic malignancies[J].Int J Radiat Oncol,1999,45(3):386-389.
  • 7Olivier C,Kong FM,Julia S,et al.Normal tissue complication probability modeling for acute esophagitis in patients treated with conformal radiation therapy for non-small cell lung cancer[J].Radiother Oncol,2005,77(2):176-181.
  • 8Huang EY,Wang CJ,Chen HC,et al.Multivariate analysis of pulmonary brosis after electron beam irradiation for postmastectomy chest wall and regional lymphatics:Evidence for non-dosimetric factors[J].Radiother Oncol,2000,57(3):91-96.

同被引文献155

引证文献16

二级引证文献99

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部